Search

Search Constraints

You searched for: Author/Creator Rutkowski, P

Search Results

1. 1623PCorrelation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinib. (23rd October 2018)

2. Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'. (5th May 2018)

3. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (3rd October 2018)

4. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes. Issue 3 (11th October 2018)

5. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (5th September 2018)

6. LBA44Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067). (23rd October 2018)

7. LBA47Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511). (23rd October 2018)

8. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (28th May 2018)

9. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (3rd October 2018)

10. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma. Issue 6 (20th February 2017)